Format

Send to

Choose Destination
J Eur Acad Dermatol Venereol. 2019 Aug 12. doi: 10.1111/jdv.15866. [Epub ahead of print]

Incidence of cardiovascular events among tildrakizumab-treated patients with moderate-to-severe plaque psoriasis: pooled data from three large randomised clinical trials.

Author information

1
Innovaderm Research, Montreal, QC, Canada.
2
Department of Dermatology, Westmead Hospital, Westmead, NSW, Australia.
3
Sydney Medical School, University of Sydney, Sydney, NSW, Australia.
4
Hospital de la Santa Creu i Sant Pau, Universitat Autònoma de Barcelona, Barcelona, Spain.
5
Sun Pharmaceutical Industries, Inc., Princeton, NJ, USA.
6
Division of Dermatology, Baylor Scott & White, Texas A&M College of Medicine, Dallas, TX, USA.
PMID:
31403725
DOI:
10.1111/jdv.15866

Supplemental Content

Full text links

Icon for Wiley
Loading ...
Support Center